Dr. Jordi Mestres has joined the Institute of Computational Chemistry and Catalysis (IQCC) at the University of Girona as a visiting professor. He is the founder of the Chemotargets SL, a pioneer company in the Catalan biotech industry that has developed benchmark software in the field of pharmacology prediction and drug safety, today the softward is